Effect of quitting smoking on health outcomes during treatment for tuberculosis: secondary analysis of the TB & Tobacco Trial:

Kamran Siddiqi, Ada Keding, Anna-Marie Marshall, Omara Dogar, Jinshuo Li, Rumana Huque, Razia Fatima, Amina Khan, Helen Elsey, Rhian Gabe, Daniel Kotz, Aziz Sheikh

16 July, 2021

NZ Respiratory Research Review Issue 199

Risk and impact of chronic cough in obese individuals from the general population:

Eskild Morten Landt, Yunus Çolak, Børge G Nordestgaard, Peter Lange, Morten Dahl

6 July, 2021

NZ Respiratory Research Review Issue 203

Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data :

Pontus Hedberg, John Karlsson Valik, Suzanne van der Werff, Hideyuki Tanushi, Ana Requena Mendez, Fredrik Granath, Max Bell, Johan Mårtensson, Robert Dyrdak, Olof Hertting, Anna Färnert, Anders Ternhag, Pontus Naucler

5 July, 2021

NZ Respiratory Research Review Issue 196

An Original Risk Score to Predict Early Major Bleeding in Acute Pulmonary Embolism - The Syncope, Anemia, Renal Dysfunction (PE-SARD) Bleeding Score:

Romain Chopard, MD, PhD Gregory Piazza, MD Nicolas Falvo, MD Fiona Ecarnot, PhD Mathieu Besutti, MD Gilles Capellier, MD, PhD François Schiele, MD, PhD Marc Badoz, MD Nicolas Meneveau, MD, PhD

1 July, 2021

NZ Respiratory Research Review Issue 195

Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial:

Kevin L. Winthrop, Patrick A. Flume, Rachel Thomson, Kevin C. Mange, Dayton W. Yuen, Monika Ciesielska, Kozo Morimoto, Stephen J. Ruoss, Luigi R. Codecasa, Jae-Joon Yim, Theodore K. Marras, Jakko van Ingen,Richard J. Wallace, Jr., Barbara A. Brown-Elliott, Chris Coulter, and David E. Griffith*; for the INS-312 Study Group

1 July, 2021

NZ Respiratory Research Review Issue 199

Postoperative continuous positive airway pressure to prevent pneumonia, re-intubation, and death after major abdominal surgery (PRISM): a multicentre, open-label, randomised, phase 3 trial:

PRISM trial group

18 June, 2021

NZ Respiratory Research Review Issue 197

Necroptosis Signaling Promotes Inflammation, Airway Remodeling, and Emphysema in Chronic Obstructive Pulmonary Disease:

Zhe Lu, Hannelore P. Van Eeckhoutte, Gang Liu, Prema M. Nair, Bernadette Jones, Caitlin M. Gillis, B. Christina Nalkurthi, Fien Verhamme, Tamariche Buyle-Huybrecht , Peter Vandenabeele, Tom Vanden Berghe, Guy G. Brusselle, Jay C. Horvat, James M. Murphy, Peter A. Wark, Ken R. Bracke, Michael Fricker, and Philip M. Hansbro

16 June, 2021

NZ Respiratory Research Review Issue 192

The association between beta-blocker therapy and daytime sleepiness in obstructive sleep apnoea:

Martina Meszaros, Alexander G. Mathioudakis, Maria Xanthoudaki, Victoria Sircu, Evangelia Nena, Jørgen Vestbo, Alexandru Corlateanu, Paschalis Steiropoulos & Andras Bikov

12 June, 2021

NZ Respiratory Research Review Issue 197

The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial:

Christine R. Jenkins, Fu-Qiang Wen, Allison Martin, Peter J. Barnes, Bartolome Celli, Nan-Shan Zhong, Jin-Ping Zheng, Anish Scaria, Gian-Luca Di Tanna, Thomas Bradbury, Norbert Berend on behalf of the TASCS study investigators

10 June, 2021

NZ Respiratory Research Review Issue 192

A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients:

Alison Moore, Andrew Preece, Raj Sharma, Liam G. Heaney, Richard W. Costello, Robert A. Wise, Andrea Ludwig-Sengpiel, Giselle Mosnaim, Jamie Rees, Ryan Tomlinson, Ruth Tal-Singer, David A. Stempel, Neil Barnes

4 June, 2021

NZ Respiratory Research Review Issue 188